Explaining the decrease in US deaths from coronary disease, 1980-2000

被引:2063
作者
Ford, Earl S.
Ajani, Umed A.
Croft, Janet B.
Critchley, Julia A.
Labarthe, Darwin R.
Kottke, Thomas E.
Giles, Wayne H.
Capewell, Simon
机构
[1] Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England
[2] Ctr Dis Control & Prevent, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA
[3] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA
[4] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[5] Healthpartners Res Fdn, Minneapolis, MN USA
基金
英国医学研究理事会;
关键词
D O I
10.1056/NEJMsa053935
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
BACKGROUND: Mortality from coronary heart disease in the United States has decreased substantially in recent decades. We conducted a study to determine how much of this decrease could be explained by the use of medical and surgical treatments as opposed to changes in cardiovascular risk factors. METHODS: We applied a previously validated statistical model, IMPACT, to data on the use and effectiveness of specific cardiac treatments and on changes in risk factors between 1980 and 2000 among U.S. adults 25 to 84 years old. The difference between the observed and expected number of deaths from coronary heart disease in 2000 was distributed among the treatments and risk factors included in the analyses. RESULTS: From 1980 through 2000, the age-adjusted death rate for coronary heart disease fell from 542.9 to 266.8 deaths per 100,000 population among men and from 263.3 to 134.4 deaths per 100,000 population among women, resulting in 341,745 fewer deaths from coronary heart disease in 2000. Approximately 47% of this decrease was attributed to treatments, including secondary preventive therapies after myocardial infarction or revascularization (11%), initial treatments for acute myocardial infarction or unstable angina (10%), treatments for heart failure (9%), revascularization for chronic angina (5%), and other therapies (12%). Approximately 44% was attributed to changes in risk factors, including reductions in total cholesterol (24%), systolic blood pressure (20%), smoking prevalence (12%), and physical inactivity (5%), although these reductions were partially offset by increases in the body-mass index and the prevalence of diabetes, which accounted for an increased number of deaths (8% and 10%, respectively). CONCLUSIONS: Approximately half the decline in U.S. deaths from coronary heart disease from 1980 through 2000 may be attributable to reductions in major risk factors and approximately half to evidence-based medical therapies.
引用
收藏
页码:2388 / 2398
页数:11
相关论文
共 53 条
[21]
PREVALENCE OF DIABETES AND IMPAIRED GLUCOSE-TOLERANCE AND PLASMA-GLUCOSE LEVELS IN UNITED-STATES POPULATION AGED 20-74 YR [J].
HARRIS, MI ;
HADDEN, WC ;
KNOWLER, WC ;
BENNETT, PH .
DIABETES, 1987, 36 (04) :523-534
[22]
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults - The Third National Health and Nutrition Examination Survey, 1988-1994 [J].
Harris, MI ;
Flegal, KM ;
Cowie, CC ;
Eberhardt, MS ;
Goldstein, DE ;
Little, RR ;
Wiedmeyer, HM ;
Byrd-Holt, DD .
DIABETES CARE, 1998, 21 (04) :518-524
[23]
Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002 [J].
Hedley, AA ;
Ogden, CL ;
Johnson, CL ;
Carroll, MD ;
Curtin, LR ;
Flegal, KM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (23) :2847-2850
[24]
Hippisley-Cox J, 2006, BRIT MED J, V332, P912
[25]
The recent decline in mortality from coronary heart disease, 1980-1990 - The effect of secular trends in risk factors and treatment [J].
Hunink, MGM ;
Goldman, L ;
Tosteson, ANA ;
Mittleman, MA ;
Goldman, PA ;
Williams, LW ;
Tsevat, J ;
Weinstein, MC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (07) :535-542
[26]
DECLINING SERUM TOTAL CHOLESTEROL LEVELS AMONG UNITED-STATES ADULTS - THE NATIONAL-HEALTH AND NUTRITION EXAMINATION SURVEYS [J].
JOHNSON, CL ;
RIFKIND, BM ;
SEMPOS, CT ;
CARROLL, MD ;
BACHORIK, PS ;
BRIEFEL, RR ;
GORDON, DJ ;
BURT, VL ;
BROWN, CD ;
LIPPEL, K ;
CLEEMAN, JI .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (23) :3002-3008
[27]
Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997 [J].
Laatikainen, T ;
Critchley, J ;
Vartiainen, E ;
Salomaa, V ;
Ketonen, M ;
Capewell, S .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 162 (08) :764-773
[28]
BY HOW MUCH AND HOW QUICKLY DOES REDUCTION IN SERUM-CHOLESTEROL CONCENTRATION LOWER RISK OF ISCHEMIC-HEART-DISEASE [J].
LAW, MR ;
WALD, NJ ;
THOMPSON, SG .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6925) :367-373
[29]
Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8
[30]
Lewington S, 2003, LANCET, V361, P1060